Oncologic Disorders Clinical Trial
Official title:
Effect of Warm Water Footbaths With Added Ginger or Mustard Powder on Psychosocial Parameters in Patients With an Oncological Disease: a Randomized Controlled Trial
A randomized, controlled, three-arm trial to investigate the effects of warm water footbaths with and without the addition of ginger or mustard powder on psychosocial parameters in patients with an oncological disease and in healthy controls.
Status | Completed |
Enrollment | 36 |
Est. completion date | September 18, 2017 |
Est. primary completion date | September 18, 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Written informed consent - Age between 18 and 65 years - Oncological disorder with at least one chemotherapy or radiation in the treatment history - Current inpatient treatment in the oncology ward of the Filderklinik (Filderstadt, Germany) with a minimum stay of 4 days Exclusion Criteria: - Infectious disease (with more than 38 °C core body temperature) - Skin lesion on the lower legs or feet - Hypersensitivity to mustard or ginger products - Cardiac arrhythmia - Pregnancy - Insufficient knowledge of the German language - Bedriddenness - Poor general condition (according to the assessment of the attending physicians) |
Country | Name | City | State |
---|---|---|---|
Germany | Arcim Institute | Filderstadt | Baden-Württemberg |
Lead Sponsor | Collaborator |
---|---|
ARCIM Institute Academic Research in Complementary and Integrative Medicine |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in subjective feeling of warmth at the feet as assessed by the "Herdecke Warmth Perception Questionnaire" from t1 to t3 | Self-reported feeling of warmth at the feet, measured with the "Herdecke Warmth Perception Questionnaire", score between 0=cold and 4=hot | Immediately before the footbath (t1) and 10 minutes following the footbath (t3) | |
Secondary | Change in subjective feeling of warmth at the feet as assessed by the "Herdecke Warmth Perception Questionnaire" from t1 to t2 | Self-reported feeling of warmth at the feet, measured with the "Herdecke Warmth Perception Questionnaire", score between 0=cold and 4=hot | Immediately before the footbath (t1) and immediately after the footbath (t2) | |
Secondary | Change in subjective feeling of warmth in the face as assessed by the "Herdecke Warmth Perception Questionnaire" from t1 to t3 | Self-reported feeling of warmth in the face, measured with the "Herdecke Warmth Perception Questionnaire", score between 0=cold and 4=hot | Immediately before the footbath (t1) and 10 minutes following the footbath (t3) | |
Secondary | Change in subjective feeling of warmth in the face as assessed by the "Herdecke Warmth Perception Questionnaire" from t1 to t2 | Self-reported feeling of warmth in the face, measured with the "Herdecke Warmth Perception Questionnaire", score between 0=cold and 4=hot | Immediately before the footbath (t1) and immediately after the footbath (t2) | |
Secondary | Change in subjective feeling of warmth at the hands as assessed by the "Herdecke Warmth Perception Questionnaire" from t1 to t3 | Self-reported feeling of warmth at the hands, measured with the "Herdecke Warmth Perception Questionnaire", score between 0=cold and 4=hot | Immediately before the footbath (t1) and 10 minutes following the footbath (t3) | |
Secondary | Change in subjective feeling of warmth at the hands as assessed by the "Herdecke Warmth Perception Questionnaire" from t1 to t2 | Self-reported feeling of warmth at the hands, measured with the "Herdecke Warmth Perception Questionnaire", score between 0=cold and 4=hot | Immediately before the footbath (t1) and immediately after the footbath (t2) | |
Secondary | Change in subjective feeling of overall warmth as assessed by the "Herdecke Warmth Perception Questionnaire" from t1 to t3 | Self-reported feeling of overall warmth, measured with the "Herdecke Warmth Perception Questionnaire", score between 0=cold and 4=hot | Immediately before the footbath (t1) and 10 minutes following the footbath (t3) | |
Secondary | Change in subjective feeling of overall warmth as assessed by the "Herdecke Warmth Perception Questionnaire" from t1 to t2 | Self-reported feeling of overall warmth, measured with the "Herdecke Warmth Perception Questionnaire", score between 0=cold and 4=hot | Immediately before the footbath (t1) and immediately after the footbath (t2) | |
Secondary | Warmth perception and skin stimulus at the feet during the footbath | Self-reported perception of warmth and skin stimulus during the footbath, assessed with a dynamic warmth and skin stimulus visual analog scale (VAS), applied once per minute (0 = cold/no stimulus; 10 = very hot/very strong stimulus) | Up to 20 minutes | |
Secondary | Change in well-being from t1 to t2 | Self-reported well-being, assessed with the "Basler Befindlichkeits-Skala" (Basel Mood Questionnaire, BBS; 16 items; 7-point rating scale; higher values | Immediately before (t1) and immediately after the footbath (t2) | |
Secondary | Change in well-being from t1 to t3 | Self-reported well-being, assessed with the "Basler Befindlichkeits-Skala" (Basel Mood Questionnaire, BBS; 16 items; 7-point rating scale; higher values represent a better outcome) | Immediately before (t1) and ten minutes following the footbath (t3) | |
Secondary | Change in skin temperature at the feet from t1 to t3 | Skin temperature (in °C) at both feet, measured with a high-definition infrared camera (FLIR-Systems, type SC660) | Immediately before (t1) and ten minutes following the footbath (t3) | |
Secondary | Change in skin temperature at the feet from t1 to t2 | Skin temperature (in °C) at both feet, measured with a high-definition infrared camera (FLIR-Systems, type SC660) | Immediately before the footbath (t1) and immediately after the footbath (t2) | |
Secondary | Change in skin temperature at the hands from t1 to t3 | Skin temperature (in °C) at both hands, measured with a high-definition infrared camera (FLIR-Systems, type SC660) | Immediately before (t1) and ten minutes following the footbath (t3) | |
Secondary | Change in skin temperature at the hands from t1 to t2 | Skin temperature (in °C) at both hands, measured with a high-definition infrared camera (FLIR-Systems, type SC660) | Immediately before the footbath (t1) and immediately after the footbath (t2) | |
Secondary | Change in skin temperature in the face from t1 to t3 | Skin temperature (in °C) in the face, measured with a high-definition infrared camera (FLIR-Systems, type SC660) | Immediately before (t1) and ten minutes following the footbath (t3) | |
Secondary | Change in skin temperature in the face from t1 to t2 | Skin temperature (in °C) in the face, measured with a high-definition infrared camera (FLIR-Systems, type SC660) | Immediately before the footbath (t1) and immediately after the footbath (t2) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT01210716 -
Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device
|
Phase 3 | |
Completed |
NCT05478733 -
Study of Factors Associated With Significant MYoCArdian Uptake on 68Ga-DOTATOC PET Scans for Oncology
|
||
Terminated |
NCT03978312 -
Nutrition Health Literacy of Cancer Patients and Their Support Networks.
|
||
Not yet recruiting |
NCT04142463 -
Collaborative Network to Take Responsibility for Oral Anticancer Therapy 2
|
N/A | |
Recruiting |
NCT06229535 -
The Right to be Forgotten in the AYA Population: Patients' Experience and Perspectives (Diritto All'Oblio)
|
||
Completed |
NCT04420039 -
Plastic Stent Within a Lumen-Apposing Stent for Malignant Biliary Obstruction
|
||
Completed |
NCT03416465 -
Place of General Medical During Oncology Care Management
|
||
Withdrawn |
NCT03041571 -
Impact of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes of Medical Students
|
||
Completed |
NCT02484053 -
Rapid Infusion Rituximab, Hematologic, Oncologic, and Rheumatologic Disorders
|
Early Phase 1 | |
Completed |
NCT03030248 -
Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients
|
Phase 2 | |
Not yet recruiting |
NCT03168048 -
Oncologic Therapy Support Via Means of a Dedicated Mobile App
|
N/A | |
Completed |
NCT03426553 -
Clinical Use of Pathogen Reduced Red Blood Cell Suspension
|
Phase 3 | |
Active, not recruiting |
NCT04842214 -
Disease Course in Oncological Patients During Inpatient Rehabilitation and After Three Months Follow-up
|
||
Completed |
NCT03272646 -
Prognostic Performance of the Naples Prognostic Score
|
N/A | |
Terminated |
NCT02285296 -
The Needs and Burden of Family Caregivers of Older Adults With Cancer
|
N/A | |
Completed |
NCT04918888 -
COVID-19 Vaccination in Oncologic Patients
|
||
Recruiting |
NCT05769868 -
Efficacy of Esmolol in the Identification of Cardiovascular Disorders by Cirrhosis, Diabetes Mellitus and Cardiotoxic Treatments
|
Phase 3 |